Literature DB >> 17719224

Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy.

P Garrood1, M Eagle, P E Jardine, K Bushby, V Straub.   

Abstract

Myoglobinuria is a recognised complication of Duchenne muscular dystrophy (DMD), but has only once been reported in ambulant boys on corticosteroid therapy [Dubowitz V, Kinali M, Main M, Mercuri E, Muntoni F. Remission of clinical signs in early Duchenne muscular dystrophy on intermittent low-dosage prednisolone therapy. Eur J Paediatr Neurol 2002;6(3):153-9.]. We present three prednisolone-treated boys with myoglobinuria and in two cases this was recurrent. All three showed improved motor performance in response to the introduction of corticosteroids. The greater activity of steroid-treated individuals may place their dystrophin-deficient muscles under greater mechanical stress, predisposing to further muscle fibre damage and consequent myoglobinuria. Families and physicians need to have an increased awareness of this possibility and of the appropriate management of myoglobinuria.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719224     DOI: 10.1016/j.nmd.2007.07.006

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Myoglobinuria as first clinical sign of a primary alpha-sarcoglycanopathy.

Authors:  Ferdinando Ceravolo; Sonia Messina; Carmelo Rodolico; Pietro Strisciuglio; Daniela Concolino
Journal:  Eur J Pediatr       Date:  2013-08-30       Impact factor: 3.183

3.  Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance.

Authors:  Carlos R Bueno Júnior; Lucas C Pantaleão; Vanessa A Voltarelli; Luiz Henrique M Bozi; Patricia Chakur Brum; Mayana Zatz
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

4.  Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients.

Authors:  Janek Hyzewicz; Urs T Ruegg; Shin'ichi Takeda
Journal:  J Neuromuscul Dis       Date:  2015-11-22

5.  Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.

Authors:  Jessica R Terrill; Basma A Al-Mshhdani; Marisa N Duong; Catherine D Wingate; Zahra Abbas; Angelo P Baustista; Amanda K Bettis; Cynthia J Balog-Alvarez; Joe N Kornegay; Peter P Nghiem; Miranda D Grounds; Peter G Arthur
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.